id	sid	eid	entity	type
asodahs-21	1	1	patel et	PERSON
asodahs-21	1	2	al asian	NORP
asodahs-21	1	3	2022	CARDINAL
asodahs-21	1	4	2(3):12	CARDINAL
asodahs-21	2	1	12	CARDINAL
asodahs-21	2	2	asian	NORP
asodahs-21	2	3	2022	CARDINAL
asodahs-21	3	1	ayushi patel	PERSON
asodahs-21	3	2	kumar jain	PERSON
asodahs-21	3	3	vivek jain	PERSON
asodahs-21	3	4	kumar khangar	PERSON
asodahs-21	3	5	adina institute of pharmaceutical sciences	ORG
asodahs-21	3	6	lahdara	GPE
asodahs-21	3	7	sagar	PERSON
asodahs-21	3	8	470001	DATE
asodahs-21	42	1	03	CARDINAL
asodahs-21	42	2	24	CARDINAL
asodahs-21	42	3	oct 2022	DATE
asodahs-21	42	4	nov 2022	DATE
asodahs-21	42	5	23	CARDINAL
asodahs-21	80	1	jain rk	PERSON
asodahs-21	80	2	jain v	PERSON
asodahs-21	80	3	khangar pk	PERSON
asodahs-21	80	4	asian	NORP
asodahs-21	80	5	2022	CARDINAL
asodahs-21	80	6	2(3):12	CARDINAL
asodahs-21	118	1	kumar khangar	PERSON
asodahs-21	118	2	adina institute of pharmaceutical sciences	ORG
asodahs-21	118	3	lahdara	GPE
asodahs-21	118	4	sagar	PERSON
asodahs-21	118	5	470001	DATE
asodahs-21	236	1	17-fold	CARDINAL
asodahs-21	237	1	100	CARDINAL
asodahs-21	237	2	rs100	GPE
asodahs-21	237	3	n-hexane	QUANTITY
asodahs-21	238	1	96.01% to 97.87%	PERCENT
asodahs-21	239	1	7.4	CARDINAL
asodahs-21	239	2	12hours	CARDINAL
asodahs-21	239	3	up to 97.22%	PERCENT
asodahs-21	239	4	12hrs	CARDINAL
asodahs-21	242	1	human1	PERSON
asodahs-21	242	2	2	CARDINAL
asodahs-21	244	1	three	CARDINAL
asodahs-21	245	1	compliance3,4	PERSON
asodahs-21	248	1	half	CARDINAL
asodahs-21	248	2	2-4 hrs	QUANTITY
asodahs-21	249	1	demonstrated5	PERSON
asodahs-21	250	1	absorption6-8	ORG
asodahs-21	250	2	carriers9	ORG
asodahs-21	251	1	one	CARDINAL
asodahs-21	253	1	11	CARDINAL
asodahs-21	254	1	14,15	CARDINAL
asodahs-21	254	2	16	CARDINAL
asodahs-21	255	1	18	DATE
asodahs-21	255	2	pluronic f-68	ORG
asodahs-21	256	1	al asian	NORP
asodahs-21	256	2	2022	CARDINAL
asodahs-21	256	3	2(3):12	CARDINAL
asodahs-21	257	1	13	CARDINAL
asodahs-21	258	1	cipla ltd	ORG
asodahs-21	258	2	mumbai	GPE
asodahs-21	258	3	india	GPE
asodahs-21	259	1	nagpur	GPE
asodahs-21	259	2	india	GPE
asodahs-21	260	1	100	CARDINAL
asodahs-21	260	2	rohm pharma gmbh	ORG
asodahs-21	260	3	germany	GPE
asodahs-21	261	1	shaw wallace	PERSON
asodahs-21	261	2	india	GPE
asodahs-21	261	3	india	GPE
asodahs-21	263	1	22	CARDINAL
asodahs-21	264	1	5 ml	QUANTITY
asodahs-21	264	2	6.8	CARDINAL
asodahs-21	264	3	7.4	CARDINAL
asodahs-21	264	4	0.1n	CARDINAL
asodahs-21	265	1	37°	QUANTITY
asodahs-21	265	2	24 hrs	DATE
asodahs-21	266	1	3000	CARDINAL
asodahs-21	266	2	about 5 minutes	TIME
asodahs-21	267	1	238	CARDINAL
asodahs-21	269	1	25 mg	QUANTITY
asodahs-21	269	2	three	CARDINAL
asodahs-21	270	1	2 hrs	TIME
asodahs-21	271	1	two	CARDINAL
asodahs-21	273	1	7.4	CARDINAL
asodahs-21	274	1	200400	CARDINAL
asodahs-21	275	1	100mg	QUANTITY
asodahs-21	275	2	7.4	CARDINAL
asodahs-21	275	3	100 ml	QUANTITY
asodahs-21	275	4	1	CARDINAL
asodahs-21	276	1	10 ml	QUANTITY
asodahs-21	276	2	1	CARDINAL
asodahs-21	276	3	100 ml	QUANTITY
asodahs-21	276	4	2	CARDINAL
asodahs-21	276	5	0.5	CARDINAL
asodahs-21	276	6	1	CARDINAL
asodahs-21	276	7	1.5	CARDINAL
asodahs-21	276	8	2	DATE
asodahs-21	276	9	2.5	CARDINAL
asodahs-21	276	10	3.0 ml	QUANTITY
asodahs-21	276	11	2	CARDINAL
asodahs-21	276	12	10 ml	QUANTITY
asodahs-21	276	13	5	CARDINAL
asodahs-21	276	14	10	DATE
asodahs-21	276	15	15	DATE
asodahs-21	276	16	20	DATE
asodahs-21	276	17	25	DATE
asodahs-21	277	1	uv1800	PRODUCT
asodahs-21	277	2	238	CARDINAL
asodahs-21	279	1	ftir	ORG
asodahs-21	279	2	kbr	PERSON
asodahs-21	279	3	0.2% to 1 %	PERCENT
asodahs-21	281	1	about 80 mg	QUANTITY
asodahs-21	283	1	4700	CARDINAL
asodahs-21	283	2	400	CARDINAL
asodahs-21	283	3	20	CARDINAL
asodahs-21	283	4	4	CARDINAL
asodahs-21	283	5	cm-1	ORG
asodahs-21	284	1	1:2	CARDINAL
asodahs-21	284	2	1:4	CARDINAL
asodahs-21	284	3	1:8	CARDINAL
asodahs-21	284	4	23	CARDINAL
asodahs-21	285	1	k-30	GPE
asodahs-21	285	2	1:2	CARDINAL
asodahs-21	285	3	1:4	CARDINAL
asodahs-21	285	4	400c	PRODUCT
asodahs-21	286	1	100	CARDINAL
asodahs-21	288	1	0.1	CARDINAL
asodahs-21	288	2	96 hrs	TIME
asodahs-21	288	3	370c	PRODUCT
asodahs-21	289	1	238	CARDINAL
asodahs-21	289	2	24	DATE
asodahs-21	290	1	ph–7.4	GPE
asodahs-21	291	1	238	CARDINAL
asodahs-21	291	2	7.4	CARDINAL
asodahs-21	292	1	1-10μg	DATE
asodahs-21	292	2	24	DATE
asodahs-21	293	1	1	CARDINAL
asodahs-21	293	2	50	CARDINAL
asodahs-21	294	1	5ml	CARDINAL
asodahs-21	294	2	5ml	CARDINAL
asodahs-21	295	1	238	CARDINAL
asodahs-21	296	1	24	DATE
asodahs-21	296	2	two	CARDINAL
asodahs-21	297	1	ese	NORP
asodahs-21	298	1	100	CARDINAL
asodahs-21	298	2	rs100	GPE
asodahs-21	298	3	n-hexane	QUANTITY
asodahs-21	298	4	1:2	CARDINAL
asodahs-21	298	5	1:4	CARDINAL
asodahs-21	298	6	each25	DATE
asodahs-21	299	1	15ml	CARDINAL
asodahs-21	301	1	15guage,2.5 inch	QUANTITY
asodahs-21	301	2	80	CARDINAL
asodahs-21	301	3	1%	PERCENT
asodahs-21	301	4	600	CARDINAL
asodahs-21	302	1	250c200c	CARDINAL
asodahs-21	302	2	al asian	NORP
asodahs-21	303	1	2022	CARDINAL
asodahs-21	303	2	2(3):12	CARDINAL
asodahs-21	304	1	14	CARDINAL
asodahs-21	306	1	n-hexane	QUANTITY
asodahs-21	307	1	26	CARDINAL
asodahs-21	307	2	ese	NORP
asodahs-21	308	1	10	CARDINAL
asodahs-21	309	1	3:2	CARDINAL
asodahs-21	310	1	ese method25,26	PERSON
asodahs-21	311	1	microcapsules27-30	CARDINAL
asodahs-21	312	1	238	CARDINAL
asodahs-21	312	2	7.4	CARDINAL
asodahs-21	313	1	1-10μg	DATE
asodahs-21	314	1	50 mg	QUANTITY
asodahs-21	314	2	7.4	CARDINAL
asodahs-21	315	1	238	CARDINAL
asodahs-21	319	1	0.1	CARDINAL
asodahs-21	319	2	2 hrs	TIME
asodahs-21	319	3	7.4	CARDINAL
asodahs-21	319	4	20%	PERCENT
asodahs-21	319	5	50	CARDINAL
asodahs-21	319	6	370c	PRODUCT
asodahs-21	319	7	up to	CARDINAL
asodahs-21	320	1	5ml	CARDINAL
asodahs-21	320	2	5ml	CARDINAL
asodahs-21	321	1	238	CARDINAL
asodahs-21	322	1	nifedipine	GPE
asodahs-21	323	1	the period of six months	DATE
asodahs-21	324	1	40°	QUANTITY
asodahs-21	324	2	75%	PERCENT
asodahs-21	325	1	six months	DATE
asodahs-21	327	1	15k	CARDINAL
asodahs-21	327	2	100%	PERCENT
asodahs-21	327	3	hitachi	ORG
asodahs-21	327	4	15	CARDINAL
asodahs-21	328	1	7.4	CARDINAL
asodahs-21	329	1	170	CARDINAL
asodahs-21	329	2	238	CARDINAL
asodahs-21	329	3	uv1800	PRODUCT
asodahs-21	330	1	5-30µg	DATE
asodahs-21	330	2	238	CARDINAL
asodahs-21	330	3	1	CARDINAL
asodahs-21	331	1	0.562	CARDINAL
asodahs-21	331	2	octanol	PERSON
asodahs-21	333	1	2	CARDINAL
asodahs-21	336	1	1:8	CARDINAL
asodahs-21	337	1	9.2%	PERCENT
asodahs-21	337	2	one	CARDINAL
asodahs-21	339	1	k-30	GPE
asodahs-21	340	1	1 & 2	ORG
asodahs-21	341	1	between 8.50 to	CARDINAL
asodahs-21	341	2	32.49 %	PERCENT
asodahs-21	341	3	8.20 to 31.69 %	PERCENT
asodahs-21	341	4	3 & 4	DATE
asodahs-21	342	1	5 & 6	DATE
asodahs-21	345	1	97.87%	PERCENT
asodahs-21	345	2	7	CARDINAL
asodahs-21	347	1	78%	PERCENT
asodahs-21	347	2	up to	CARDINAL
asodahs-21	347	3	94.012%	PERCENT
asodahs-21	347	4	82.32 %	PERCENT
asodahs-21	347	5	98.22%	PERCENT
asodahs-21	347	6	up to	CARDINAL
asodahs-21	350	1	mese	GPE
asodahs-21	351	1	3	CARDINAL
asodahs-21	352	1	six months	DATE
asodahs-21	353	1	4	CARDINAL
asodahs-21	355	1	5	CARDINAL
asodahs-21	355	2	patel et	PERSON
asodahs-21	355	3	al asian	NORP
asodahs-21	355	4	2022	CARDINAL
asodahs-21	356	1	2(3):12	CARDINAL
asodahs-21	357	1	15	CARDINAL
asodahs-21	357	2	1	CARDINAL
asodahs-21	357	3	2	CARDINAL
asodahs-21	357	4	1	CARDINAL
asodahs-21	357	5	1:2	CARDINAL
asodahs-21	358	1	1:4	CARDINAL
asodahs-21	358	2	7.483	CARDINAL
asodahs-21	358	3	9.905	CARDINAL
asodahs-21	358	4	8.963	CARDINAL
asodahs-21	358	5	2	CARDINAL
asodahs-21	358	6	1:2	CARDINAL
asodahs-21	358	7	12.321	CARDINAL
asodahs-21	358	8	15.65 17.898	CARDINAL
asodahs-21	358	9	8.94	CARDINAL
asodahs-21	358	10	3	CARDINAL
asodahs-21	359	1	mg %	PERCENT
asodahs-21	359	2	1:2	CARDINAL
asodahs-21	360	1	1:4	CARDINAL
asodahs-21	360	2	3	CARDINAL
asodahs-21	360	3	14.28	CARDINAL
asodahs-21	360	4	4	CARDINAL
asodahs-21	360	5	11.11	CARDINAL
asodahs-21	361	1	8.50	CARDINAL
asodahs-21	361	2	patel et	PERSON
asodahs-21	361	3	al asian journal	ORG
asodahs-21	361	4	2022	CARDINAL
asodahs-21	361	5	2(3):12	CARDINAL
asodahs-21	361	6	16	CARDINAL
asodahs-21	361	7	4	CARDINAL
asodahs-21	362	1	1	CARDINAL
asodahs-21	362	2	1:2	CARDINAL
asodahs-21	363	1	2	CARDINAL
asodahs-21	363	2	1:4	CARDINAL
asodahs-21	363	3	3	CARDINAL
asodahs-21	363	4	14.28	CARDINAL
asodahs-21	363	5	4	CARDINAL
asodahs-21	363	6	11.11	CARDINAL
asodahs-21	364	1	1:10 9.09 8.20	CARDINAL
asodahs-21	364	2	5	CARDINAL
asodahs-21	364	3	1:2	CARDINAL
asodahs-21	364	4	1:4	CARDINAL
asodahs-21	364	5	0	CARDINAL
asodahs-21	364	6	10.9	CARDINAL
asodahs-21	364	7	9.29 13.91	CARDINAL
asodahs-21	364	8	6	CARDINAL
asodahs-21	364	9	1:2	CARDINAL
asodahs-21	364	10	1:4	CARDINAL
asodahs-21	364	11	0	CARDINAL
asodahs-21	364	12	15.72	CARDINAL
asodahs-21	364	13	1.82	CARDINAL
asodahs-21	364	14	28.57	CARDINAL
asodahs-21	364	15	2.2	CARDINAL
asodahs-21	364	16	19.8	CARDINAL
asodahs-21	364	17	35.21	CARDINAL
asodahs-21	364	18	39.56	CARDINAL
asodahs-21	364	19	63.21	CARDINAL
asodahs-21	364	20	78.92	MONEY
asodahs-21	364	21	60 9.2	CARDINAL
asodahs-21	364	22	87.65	CARDINAL
asodahs-21	364	23	7	CARDINAL
asodahs-21	364	24	99.97	CARDINAL
asodahs-21	364	25	10.89	MONEY
asodahs-21	364	26	8.79 96.69	CARDINAL
asodahs-21	364	27	10.76	CARDINAL
asodahs-21	364	28	8.89	CARDINAL
asodahs-21	364	29	97.87	CARDINAL
asodahs-21	364	30	patel et	PERSON
asodahs-21	364	31	al asian	NORP
asodahs-21	364	32	2022	CARDINAL
asodahs-21	364	33	2(3):12	CARDINAL
asodahs-21	364	34	17	CARDINAL
asodahs-21	364	35	3	CARDINAL
asodahs-21	364	36	4	CARDINAL
asodahs-21	364	37	5	CARDINAL
asodahs-21	370	1	up to 97.22%	PERCENT
asodahs-21	370	2	12hrs	CARDINAL
asodahs-21	371	1	1	CARDINAL
asodahs-21	372	1	akinboboye o	ORG
asodahs-21	372	2	idris o	PERSON
asodahs-21	372	3	africans	NORP
asodahs-21	373	1	j hum hypertens	PERSON
asodahs-21	374	1	2003	DATE
asodahs-21	374	2	17(6):381-7	DATE
asodahs-21	374	3	2	CARDINAL
asodahs-21	374	4	okpechi ig	ORG
asodahs-21	374	5	rayner bl.	PERSON
asodahs-21	376	1	clin investig	PERSON
asodahs-21	376	2	2011	DATE
asodahs-21	376	3	1(8):1141-54	DATE
asodahs-21	377	1	al asian journal	ORG
asodahs-21	377	2	2022	CARDINAL
asodahs-21	377	3	2(3):12	CARDINAL
asodahs-21	377	4	18	CARDINAL
asodahs-21	377	5	3	CARDINAL
asodahs-21	377	6	barakat ns	PERSON
asodahs-21	377	7	almurshedi	PERSON
asodahs-21	379	1	2011	DATE
asodahs-21	379	2	63(2):16978	CARDINAL
asodahs-21	379	3	4	CARDINAL
asodahs-21	379	4	sousa e silva jp	PERSON
asodahs-21	379	5	lobo	PERSON
asodahs-21	379	6	bonifácio mj	PERSON
asodahs-21	379	7	machado	PERSON
asodahs-21	379	8	göttingen minipigs	PERSON
asodahs-21	380	1	j pharm pharmacol	PERSON
asodahs-21	381	1	2011	DATE
asodahs-21	381	2	63(6):780-5	CARDINAL
asodahs-21	382	1	5	CARDINAL
asodahs-21	383	1	soleymani m.	PERSON
asodahs-21	384	1	asian	NORP
asodahs-21	385	1	2010	DATE
asodahs-21	385	2	4(4):185	CARDINAL
asodahs-21	387	1	lin sl	PERSON
asodahs-21	387	2	menig j	PERSON
asodahs-21	387	3	lachman l. interdependence	PERSON
asodahs-21	388	1	sci	ORG
asodahs-21	388	2	1968	DATE
asodahs-21	388	3	57(12):2143	CARDINAL
asodahs-21	389	1	https://doi.org/10.1002/jps.2600571225 7	ORG
asodahs-21	389	2	kornblum ss	PERSON
asodahs-21	390	1	sci	ORG
asodahs-21	390	2	1970	DATE
asodahs-21	390	3	56:606-614	CARDINAL
asodahs-21	391	1	8	CARDINAL
asodahs-21	392	1	parrot el	GPE
asodahs-21	394	1	j pharma sci.	PERSON
asodahs-21	394	2	1974	DATE
asodahs-21	394	3	63:813-820	CARDINAL
asodahs-21	395	1	9	CARDINAL
asodahs-21	395	2	chiou wl	PERSON
asodahs-21	395	3	riegelman s. pharmaceutical application	PERSON
asodahs-21	396	1	j pharma sci.1971	PERSON
asodahs-21	396	2	60:1281-1302	DATE
asodahs-21	397	1	10	CARDINAL
asodahs-21	398	1	serajuddin	ORG
asodahs-21	400	1	sci	ORG
asodahs-21	400	2	1999	DATE
asodahs-21	400	3	88:1058-1066	DATE
asodahs-21	401	1	11	CARDINAL
asodahs-21	402	1	sheen p	ORG
asodahs-21	404	1	1995	DATE
asodahs-21	404	2	118:221-227	CARDINAL
asodahs-21	406	1	sahu v	PERSON
asodahs-21	406	2	jadon	GPE
asodahs-21	406	3	jain pk	PERSON
asodahs-21	406	4	khare b	ORG
asodahs-21	407	1	2021	CARDINAL
asodahs-21	407	2	7(2):1-9 https://doi.org/10.22270/ijmspr.v7i2.53 13	TIME
asodahs-21	408	1	augustijns p	PERSON
asodahs-21	408	2	blaton n	PERSON
asodahs-21	408	3	r. physico-chemical	PERSON
asodahs-21	408	4	6000	CARDINAL
asodahs-21	408	5	pvp k30	PERSON
asodahs-21	410	1	1998	DATE
asodahs-21	410	2	164:6780	CARDINAL
asodahs-21	411	1	14	CARDINAL
asodahs-21	413	1	k-30	GPE
asodahs-21	415	1	1996	DATE
asodahs-21	415	2	143:59-66	DATE
asodahs-21	416	1	11	CARDINAL
asodahs-21	417	1	15	CARDINAL
asodahs-21	417	2	torrado s	PERSON
asodahs-21	417	3	cadorniga r. preparation	PERSON
asodahs-21	418	1	1996	DATE
asodahs-21	418	2	140:247-250	DATE
asodahs-21	420	1	ho h	GPE
asodahs-21	420	2	su h	GPE
asodahs-21	420	3	tsai t	PERSON
asodahs-21	422	1	19996	DATE
asodahs-21	423	1	139:223229	CARDINAL
asodahs-21	425	1	kearney	PERSON
asodahs-21	425	2	patel k	PERSON
asodahs-21	425	3	zuber g	PERSON
asodahs-21	426	1	sb-210661	PRODUCT
asodahs-21	426	2	5	CARDINAL
asodahs-21	428	1	1998	DATE
asodahs-21	428	2	176:31	CARDINAL
asodahs-21	430	1	nair r	PERSON
asodahs-21	430	2	hoag sw	ORG
asodahs-21	433	1	2002	DATE
asodahs-21	434	1	240:11	CARDINAL
asodahs-21	434	2	19	CARDINAL
asodahs-21	435	1	mehta ka	PERSON
asodahs-21	435	2	kislalioghu ms	PERSON
asodahs-21	435	3	phuapradit w	PERSON
asodahs-21	435	4	malick w	PERSON
asodahs-21	435	5	shah nh	GPE
asodahs-21	435	6	pluronic	NORP
asodahs-21	436	1	drug dev ind pharm	ORG
asodahs-21	437	1	2002	DATE
asodahs-21	437	2	28:275-286	CARDINAL
asodahs-21	438	1	https://doi.org/10.1081/ddc-120002843 20	DATE
asodahs-21	439	1	nagarajan k	PERSON
asodahs-21	439	2	rao mg	PERSON
asodahs-21	441	1	indian	NORP
asodahs-21	441	2	2010	DATE
asodahs-21	441	3	2:96-98	DATE
asodahs-21	442	1	21	CARDINAL
asodahs-21	443	1	jain np	PERSON
asodahs-21	446	1	2015	CARDINAL
asodahs-21	446	2	2(2):51-8	ORG
asodahs-21	446	3	lee	PERSON
asodahs-21	448	1	eur j pharm biopharm	ORG
asodahs-21	449	1	2013	DATE
asodahs-21	449	2	85(3):799-813	CARDINAL
asodahs-21	450	1	23	CARDINAL
asodahs-21	451	1	chowdary kpr	PERSON
asodahs-21	451	2	ramesh s. microencapsulation	PERSON
asodahs-21	452	1	indian	NORP
asodahs-21	452	2	1995	DATE
asodahs-21	452	3	32	CARDINAL
asodahs-21	452	4	10):477483	CARDINAL
asodahs-21	452	5	24	CARDINAL
asodahs-21	453	1	arias mj	PERSON
asodahs-21	453	2	gines jm	PERSON
asodahs-21	453	3	moyano jr	PERSON
asodahs-21	455	1	pharmaceutica acta helvetiae	PERSON
asodahs-21	456	1	1996	DATE
asodahs-21	457	1	71(4):229-35	DATE
asodahs-21	458	1	https://doi.org/10.1016/s0031-6865(96)00017-9 25	DATE
asodahs-21	459	1	nokhodchi	PERSON
asodahs-21	459	2	d. microencapsulation	PERSON
asodahs-21	460	1	pharm tech north america	ORG
asodahs-21	461	1	2002	DATE
asodahs-21	462	1	26(6):54-60	DATE
asodahs-21	463	1	26	CARDINAL
asodahs-21	464	1	wu	PERSON
asodahs-21	464	2	huang yb	PERSON
asodahs-21	464	3	chang js	PERSON
asodahs-21	464	4	tsai mj	PERSON
asodahs-21	464	5	tsai	PERSON
asodahs-21	465	1	eur j pharm sci	ORG
asodahs-21	465	2	2003	DATE
asodahs-21	465	3	19(23):115-22	DATE
asodahs-21	466	1	https://doi.org/10.1016/s0928-0987(03)00069-1 27	DATE
asodahs-21	467	1	gautam	PERSON
asodahs-21	467	2	rai jp	PERSON
asodahs-21	467	3	billshaiya u	PERSON
asodahs-21	467	4	jain dk.	PERSON
asodahs-21	468	1	sci res	ORG
asodahs-21	469	1	2013	DATE
asodahs-21	469	2	4(5):1782	CARDINAL
asodahs-21	470	1	28	CARDINAL
asodahs-21	471	1	jain dk	PERSON
asodahs-21	472	1	sci	ORG
asodahs-21	472	2	2012	DATE
asodahs-21	472	3	4(4):355	CARDINAL
asodahs-21	472	4	29	CARDINAL
asodahs-21	473	1	pandey sp	PERSON
asodahs-21	473	2	khan ma	PERSON
asodahs-21	473	3	jain dk.	GPE
asodahs-21	474	1	sch acad j pharm	ORG
asodahs-21	475	1	2019	CARDINAL
asodahs-21	475	2	8(3):57-73	DATE
asodahs-21	476	1	30	CARDINAL
asodahs-21	477	1	jain p	PERSON
asodahs-21	477	2	nair s	PERSON
asodahs-21	477	3	jain dk	GPE
asodahs-21	477	4	jain s.	PERSON
asodahs-21	478	1	sci 2012	ORG
asodahs-21	478	2	3(4):604-608	DATE
asodahs-21	480	1	https://doi.org/10.1016/0378-5173(94)00366-d https://doi.org/10.22270/ijmspr.v7i2.53 https://doi.org/10.1016/s0378-5173(97)00401-8 https://doi.org/10.1016/s0378-5173(96)04687-x	PERSON